Masimo Co. (NASDAQ:MASI) Stock Position Decreased by Farallon Capital Management LLC

Farallon Capital Management LLC lowered its position in Masimo Co. (NASDAQ:MASI) by 24.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,119,563 shares of the medical equipment provider’s stock after selling 370,000 shares during the period. Farallon Capital Management LLC’s holdings in Masimo were worth $140,998,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Riverview Trust Co acquired a new stake in shares of Masimo in the 1st quarter valued at $25,000. GAMMA Investing LLC lifted its position in shares of Masimo by 75.0% in the second quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock worth $33,000 after buying an additional 111 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Masimo by 851.6% during the 4th quarter. EverSource Wealth Advisors LLC now owns 295 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 264 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of Masimo by 48.3% in the 4th quarter. Parallel Advisors LLC now owns 445 shares of the medical equipment provider’s stock valued at $52,000 after acquiring an additional 145 shares in the last quarter. Finally, HHM Wealth Advisors LLC lifted its holdings in Masimo by 25.0% in the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock worth $79,000 after purchasing an additional 125 shares during the last quarter. 85.96% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on MASI. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Friday. Piper Sandler upped their price target on shares of Masimo from $160.00 to $165.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $144.67.

Masimo Price Performance

NASDAQ:MASI opened at $125.00 on Tuesday. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. The stock has a market cap of $6.65 billion, a P/E ratio of 85.03 and a beta of 0.98. The company has a fifty day moving average price of $115.33 and a 200 day moving average price of $124.91. Masimo Co. has a one year low of $75.22 and a one year high of $153.93.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.09. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The business had revenue of $496.30 million during the quarter, compared to analyst estimates of $493.92 million. During the same quarter in the prior year, the business earned $0.62 earnings per share. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. Analysts anticipate that Masimo Co. will post 3.87 earnings per share for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.